NDA 018337 · Taro
Acetaminophen
Acetaminophen · Rectal
Last checked: Nov 19, 2026Latest source record: Feb 7, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1980
Apr 22, 1980
Approved uses
1
Original approval plus efficacy supplements
Registered trials
1,695
325 Phase 3, 144 recruiting
FAERS reports
261,279
227,860 serious, 51,167 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Sep 3, 2026.
Uses temporarily reduces fever relieves minor aches, pains, and headache
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Apr 22, 1980 Original approval · Type 5 - New Formulation or New Manufacturer
4 products under this application
- ACETAMINOPHEN · ACETAMINOPHEN 120MG · SUPPOSITORY, RECTAL · Over-the-counter
- ACETAMINOPHEN · ACETAMINOPHEN 650MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SUPPOSITORY, RECTAL · Discontinued
- INFANTS' FEVERALL · ACETAMINOPHEN 80MG · SUPPOSITORY, RECTAL · Over-the-counter
- ACETAMINOPHEN · ACETAMINOPHEN 325MG · SUPPOSITORY, RECTAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Acetaminophen" as an intervention, any sponsor and status, largest first.
OMNI Medical Services, LLCResearch network
NCT03944447 · 200,000 participants (planned) · Start Dec 1, 2018 · Primary completion Dec 31, 2025
Drug: Cannabis, Medical · For: Chronic Pain; Chronic Pain Syndrome; Chronic Pain Due to Injury and 30 more
Sites: Boca Raton, Florida; Bradenton, Florida; Fort Lauderdale, Florida · 17 sites in all
- A Study of a Candidate COVID-19 Vaccine (COV003)Pivotal-lookingStatus unknown
University of OxfordAcademic, hospital or other
NCT04536051 · 10,300 participants (planned) · Start Jun 2, 2020 · Primary completion Sep 2021
Drug: ChAdOx1 nCoV-19 single dose + paracetamol; MenACWY single dose + paracetamol and 2 more · For: Coronavirus
Sites: Salvador, Brazil; Natal, Brazil; Porto Alegre, Brazil · 6 sites in all
- Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTsPivotal-lookingCompleted
Mbarara University of Science and TechnologyAcademic, hospital or other
NCT00720811 · 6,456 participants · Start Oct 2009 · Primary completion Jan 2012
Drug: Artemether-lumefantrine combination; amoxycillin and 2 more · For: Malaria; Pneumonia
Sites: Saponé, Burkina Faso; Kassane, Ghana; Iganga, Uganda · 4 sites in all
- To Relieve Pain and Anxiety - an Intervention Study in Ambulance ServicesPivotal-lookingCompleted
Sahlgrenska University HospitalAcademic, hospital or other
NCT00792181 · 2,800 participants (planned) · Start Jun 2008 · Primary completion Nov 2008
Drug: Midazolam · For: Acute Myocardial Infarction; Pain
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Pivotal-lookingRecruiting
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT06966700 · 2,400 participants (planned) · Start Jun 30, 2025 · Primary completion Mar 23, 2033
Drug: Sacituzumab tirumotecan; Pembrolizumab and 8 more · For: Breast Neoplasms; Triple Negative Breast Neoplasms; HR Low-Positive/HER2-Negative Breast Neoplasms
Sites: Gilbert, Arizona; Phoenix, Arizona; Tucson, Arizona · 338 sites in all
- A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis PainPivotal-lookingCompleted
Johns Hopkins UniversityAcademic, hospital or other
NCT04504812 · 1,937 participants · Start Feb 1, 2021 · Primary completion Apr 8, 2025
Drug: Duloxetine · For: Knee Osteoarthritis
Sites: Sacramento, California; San Diego, California; Aurora, Colorado · 24 sites in all
- Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From Major Noncardiac SurgeryPivotal-lookingNot yet recruiting
RenJi HospitalAcademic, hospital or other
NCT06653465 · 1,930 participants (planned) · Start Jun 2025 · Primary completion Jun 2027
Drug: Acetaminophen; Saline · For: Delirium in Old Age
- Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache PatientsPivotal-lookingCompleted
Boehringer IngelheimBoehringer Ingelheim
NCT02183688 · 1,889 participants · Start Sep 1998 · Primary completion Jan 2003
Drug: Low dose ASA; High dose ASA and 4 more · For: Migraine Disorders
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- off label use23,643
- fatigue21,355
- drug ineffective19,055
- pain18,805
- nausea18,668
- headache17,530
- toxicity to various agents16,856
- dyspnoea15,395
- vomiting14,905
- pyrexia14,843
- arthralgia14,758
- diarrhoea14,080
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 2,590 |
| 2005 | 2,685 |
| 2006 | 3,150 |
| 2007 | 2,550 |
| 2008 | 3,882 |
| 2009 | 3,069 |
| 2010 | 3,843 |
| 2011 | 8,184 |
| 2012 | 8,165 |
| 2013 | 3,385 |
| 2014 | 4,018 |
| 2015 | 6,122 |
| 2016 | 8,307 |
| 2017 | 7,474 |
| 2018 | 9,223 |
| 2019 | 12,638 |
| 2020 | 19,805 |
| 2021 | 20,050 |
| 2022 | 27,215 |
| 2023 | 27,956 |
| 2024 | 28,660 |
| 2025 | 28,275 |
| 2026 | 20,022 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Part D: Acetaminophen (Acetaminophen)
2024 spending
$126K
Beneficiaries
305
734 claims
Per beneficiary
$413
$0.20 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $0 |
| 2021 | $35,877 |
| 2022 | $59,928 |
| 2023 | $48,943 |
| 2024 | $125,891 |
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis.
Tan E, Braithwaite I, McKinlay CJD, et al. · JAMA Netw Open 2020 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Tramadol (with or without acetaminophen) efficacy and harm: Systematic review and meta-analysis.
Otte JA, Chu G, Heran B, et al. · Can Fam Physician 2025 · Systematic Review, Meta-Analysis
- Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data.
Zeng C, Doherty M, Persson MSM, et al. · Osteoarthritis Cartilage 2021 · Comparative Study, Research Support, Non-U.S. Gov't
- Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies.
Masarwa R, Levine H, Gorelik E, et al. · Am J Epidemiol 2018 · Meta-Analysis, Systematic Review
- Acute Postoperative Pain Due to Dental Extraction in the Adult Population: A Systematic Review and Network Meta-analysis.
Miroshnychenko A, Ibrahim S, Azab M, et al. · J Dent Res 2023 · Systematic Review, Research Support, Non-U.S. Gov't
- Systematic Review and Meta-Analysis: Acetaminophen Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Childhood.
Bérard A, Cottin J, Leal LF, et al. · J Am Acad Child Adolesc Psychiatry 2026 · Systematic Review, Meta-Analysis
Sponsor: Taro · Also marketed as Infants' Feverall
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.